743 related articles for article (PubMed ID: 22483867)
21. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
22. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.
Mosser J; Douar AM; Sarde CO; Kioschis P; Feil R; Moser H; Poustka AM; Mandel JL; Aubourg P
Nature; 1993 Feb; 361(6414):726-30. PubMed ID: 8441467
[TBL] [Abstract][Full Text] [Related]
23. Cerebral inflammation in X-linked adrenoleukodystrophy.
McGuinness MC; Smith KD
Arch Immunol Ther Exp (Warsz); 1999; 47(5):281-7. PubMed ID: 10604233
[TBL] [Abstract][Full Text] [Related]
24. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
[TBL] [Abstract][Full Text] [Related]
25. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
[TBL] [Abstract][Full Text] [Related]
26. X-linked adrenoleukodystrophy and primary adrenal insufficiency.
Cappa M; Todisco T; Bizzarri C
Front Endocrinol (Lausanne); 2023; 14():1309053. PubMed ID: 38034003
[TBL] [Abstract][Full Text] [Related]
27. X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
Weinhofer I; Forss-Petter S; Kunze M; Zigman M; Berger J
FEBS Lett; 2005 Oct; 579(25):5512-6. PubMed ID: 16213491
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
McGuinness MC; Zhang HP; Smith KD
Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
[TBL] [Abstract][Full Text] [Related]
29. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
Weber FD; Wiesinger C; Forss-Petter S; Regelsberger G; Einwich A; Weber WH; Köhler W; Stockinger H; Berger J
Hum Mol Genet; 2014 May; 23(10):2542-50. PubMed ID: 24363066
[TBL] [Abstract][Full Text] [Related]
30. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
[TBL] [Abstract][Full Text] [Related]
31. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
[TBL] [Abstract][Full Text] [Related]
32. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters.
van Roermund CW; Visser WF; Ijlst L; van Cruchten A; Boek M; Kulik W; Waterham HR; Wanders RJ
FASEB J; 2008 Dec; 22(12):4201-8. PubMed ID: 18757502
[TBL] [Abstract][Full Text] [Related]
33. Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
Braiterman LT; Watkins PA; Moser AB; Smith KD
Mol Genet Metab; 1999 Feb; 66(2):91-9. PubMed ID: 10068511
[TBL] [Abstract][Full Text] [Related]
34. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of ABCD1 gene in Indian patients with X-linked adrenoleukodystrophy.
Shukla P; Gupta N; Gulati S; Ghosh M; Vasisht S; Sharma R; Gupta AK; Kalra V; Kabra M
Clin Chim Acta; 2011 Nov; 412(23-24):2289-95. PubMed ID: 21889498
[TBL] [Abstract][Full Text] [Related]
36. X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans.
Curiel J; Steinberg SJ; Bright S; Snowden A; Moser AB; Eichler F; Dubbs HA; Hacia JG; Ely JJ; Bezner J; Gean A; Vanderver A
Mol Genet Metab; 2017 Nov; 122(3):130-133. PubMed ID: 28919002
[TBL] [Abstract][Full Text] [Related]
37. [Prenatal diagnosis of X-linked adrenoleukodystrophy].
Bao XH; Ping LL; Wang AH; Pan H; Wu Y; Xiong H; Zhang YH; Shi CY; Qin J; Wu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):1-5. PubMed ID: 17285533
[TBL] [Abstract][Full Text] [Related]
38. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.
Engelen M; Barbier M; Dijkstra IM; Schür R; de Bie RM; Verhamme C; Dijkgraaf MG; Aubourg PA; Wanders RJ; van Geel BM; de Visser M; Poll-The BT; Kemp S
Brain; 2014 Mar; 137(Pt 3):693-706. PubMed ID: 24480483
[TBL] [Abstract][Full Text] [Related]
39. Eight novel mutations in the ABCD1 gene and clinical characteristics of 25 Chinese patients with X-linked adrenoleukodystrophy.
Chu SS; Ye J; Zhang HW; Han LS; Qiu WJ; Gao XL; Gu XF
World J Pediatr; 2015 Nov; 11(4):366-73. PubMed ID: 26454440
[TBL] [Abstract][Full Text] [Related]
40. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.
Braiterman LT; Zheng S; Watkins PA; Geraghty MT; Johnson G; McGuinness MC; Moser AB; Smith KD
Hum Mol Genet; 1998 Feb; 7(2):239-47. PubMed ID: 9425230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
